Vir Biotechnology, Inc. Share Price
NASDAQ: VIR | Small CapVir Biotechnology, Inc. Stock Performance
Open $8.87 | Prev. Close $8.78 | Circuit Range N/A |
Day Range $8.77 - $9.03 | Year Range $4.16 - $11.47 | Volume 86,850 |
Average Traded $8.89 |
Vir Biotechnology, Inc. Share Price Today
As of 10 August 2026, Vir Biotechnology, Inc.'s share price is $8.82. The stock opened at $8.87, compared to its previous close of $8.78. During today's trading session, Vir Biotechnology, Inc.'s share price traded between $8.77 and $9.03, with an average price of $8.90. Over the past 52 weeks, the stock has recorded a high of $11.47 and a low of $4.16. In terms of performance, Vir Biotechnology, Inc.'s share price has declined by 2.97% over the last six months and is up 78.18% on a year-on-year basis.
Vir Biotechnology, Inc. Share Price Chart
Vir Biotechnology, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.22B | PE Ratio (TTM) -2.79 | Dividend Yield N/A |
EPS (TTM) $-3.16 | Revenue (TTM) $68.56M | Return On Equity (TTM) -57.23% |
Profit Margin -638.87% | Debt to Equity 0.12 | Quarterly Earnings Growth YoY 23.66% |
Vir Biotechnology, Inc. Quarterly Profit & Loss
All figures in USD
Vir Biotechnology, Inc. Annual Profit & Loss
All figures in USD
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Vir Biotechnology, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.69 | $8.82 | +1.85% |
Jul 2026 | $10.27 | $8.66 | -14.89% |
Jun 2026 | $9.42 | $10.18 | +6.77% |
May 2026 | $10.20 | $9.53 | -6.71% |
Apr 2026 | $9.10 | $10.21 | +14.13% |
Mar 2026 | $8.91 | $8.95 | -1.54% |
Feb 2026 | $7.34 | $9.09 | +22.18% |
Jan 2026 | $6.01 | $7.44 | +23.59% |
Dec 2025 | $6.27 | $6.02 | -6.38% |
Nov 2025 | $5.82 | $6.43 | +8.07% |
Oct 2025 | $5.70 | $5.95 | +4.20% |
Sep 2025 | $4.93 | $5.71 | +15.35% |
VIR Share Price FAQs
What is Vir Biotechnology, Inc. share price today?
What is the 52 week high and 52 week low of Vir Biotechnology, Inc. stock?
What is VIR's market capitalisation today?
What is VIR's net income for the last quarter?
What is the 5 year returns of VIR?
What is the high & low stock price of VIR today?
Can I buy VIR shares in India?